Antibiotic treatment for bacterial meningitis in children in developing countries

Annals of Tropical Paediatrics

Volumn 23, Issue 4, 2003, Pages 233-253

  Fuller, David G ^a   Duke, Trevor ^a,b   Shann, Frank ^a,b   Curtis, Nigel ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL VACCINE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; DEXAMETHASONE; LONG ACTING DRUG; PARACETAMOL; PENICILLIN G; PHENOBARBITAL;

ANTIBIOTICS; CHILD HEALTH; DEVELOPING WORLD; DISEASE CONTROL; MENINGITIS;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL MENINGITIS; BACTERIAL VIRULENCE; CAUSE OF DEATH; CHILD; CHILD NUTRITION; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DEVELOPING COUNTRY; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG COST; DRUG POTENTIATION; EMPIRICISM; EVIDENCE BASED MEDICINE; HEALTH CARE ACCESS; HUMAN; NEUROLOGIC DISEASE; PATIENT COMPLIANCE; PENICILLIN RESISTANCE; RESOURCE MANAGEMENT; REVIEW; SIDE EFFECT; SURVIVAL RATE;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CHILD, PRESCHOOL; CHLORAMPHENICOL; DEVELOPING COUNTRIES; DRUG ADMINISTRATION ROUTES; DRUG RESISTANCE, BACTERIAL; HUMANS; INFANT; MENINGITIS, BACTERIAL; PENICILLINS;

EID: 0346733189     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1179/027249303225007752     Document Type: Review

References (102)

1. Murray CJL, Lopez AD. Global and regional cause of death patterns in 1990. In: Murray CJL, Lopez AD, eds. Global Comparative Assessments in the Health Sector: Disease Burden, Expenditures and Intervention Packages. Geneva: WHO, 1994; 21-55.
2. Macaluso A, Pivetta S, Maggi RS, Tamburlini G, Cattaneo A. Dexamethasone adjunctive therapy for bacterial meningitis in children: a retrospective study in Brazil. Ann Trop Paediatr 1996; 16:193-8
3. Imananagha KK, Peters EJ, Philip-Ephraim EE, et al. Acute bacterial meningitis in a developing country: diagnosis related mortality among paediatric patients. Cent Afr J Med 1998; 44:11-15.
4. Peltola H. Burden of meningitis and other severe bacterial infections of children in Africa: implications for prevention. Clin Infect Dis 2001; 32:64-75.
5. Peltola H. Spectrum and burden of severe Haemophilus influenzae type b diseases in Asia. Bull WHO 1999; 77:878-87.
6. Wills B, Farrer J. Central nervous system infections in the tropics: diagnosis, treatment and prevention. Curr Opin Infect Dis 2000; 13:259-64.
7. Lau YL, Low LC, Yung R, et al. Invasive Haemophilus influenzae type b infections in children hospitalized in Hong Kong, 1986-1990. Hong Kong Hib Study Group. Acta Paediatr 1995; 84:173-6.
8. Berkley J, Mwangi I, Ngetsa C, et al. Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa. Lancet 2001; 357:1753-7.
9. Moosa AA, Quortum HA, Ibrahim MD. Rapid diagnosis of bacterial meningitis with reagent strips. Lancet 1995; 345:1290-1.
10. Molyneux EM, Walsh AL, Phiri AJ, Soko D, Tembo M, Howarth I. Does the use of urinary reagent strip tests improve the bedside diagnosis of meningitis? Trans R Soc Trop Med Hyg 1999; 93:409-10.
11. Marcos M, Martinez E, Almela M, Mensa J, Jimenez de Anta M. New rapid antigen test for diagnosis of pneumococcal meningitis. Lancet 2001; 357:1499-500.
12. Sormunen P, Kallio MJ, Kilpi T, Peltola H. C-reactive protein is useful in distinguishing Gram stain-negative bacterial meningitis from viral meningitis in children. J Pediatr 1999; 134:725-9.
13. Tatara R, Imai H. Serum C-reactive protein in the differential diagnosis of childhood meningitis. Pediatr Int 2000; 42:541-6.
14. Sutinen J, Sombrero L, Paladin FJ, et al. Etiology of central nervous system infections in the Philippines and the role of serum C-reactive protein in excluding acute bacterial meningitis. Int J Infect Dis 1998; 3:88-93.
15. Roine I, Banfi A, Bosch P, Ledermann W, Contreras C, Peltola H. Serum C-reactive protein in childhood meningitis in countries with limited laboratory resources: a Chilean experience. Pediatr Infect Dis J 1991; 10:923-8.
16. De Beer FC, Kirsten GF, Gie RP, Beyers N, Strachan AF. Value of C reactive protein measurement in tuberculous, bacterial, and viral meningitis. Arch Dis Child 1984; 59:653-6.
17. Gerdes LU, Jorgensen PE, Nexo E, Wang P. C-reactive protein and bacterial meningitis: a meta-analysis. Scand J Clin Lab Invest 1998; 58:383-93.
18. Rennick G, Shann F, de Campo J. Cerebral herniation during bacterial meningitis in children. Br Med J 1993; 306:953-5.
19. Lehmann D, Yeka W, Rongap T, et al. Aetiology and clinical signs of bacterial meningitis in children admitted to Goroka Base Hospital, Papua New Guinea, 1989-1992. Ann Trop Paediatr 1999; 19:21-32.
20. Duke T, Poka H, Dale F, Michael A, Mgone J, Wal T. Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial. Lancet 2002; 359:474-80.
21. Rohdenburg GL, Van der Veer A. The spinal fluid in pneumonia. JAMA 1915; 64:1227-8.
22. Hansman D, Bullen MM. A resistant pneumococcus. Lancet 1967; 2:264-5.
23. Gratten M, Naraqi S, Hansman D. High prevalence of penicillin-insensitive pneumococci in Port Moresby, Papua New Guinea. Lancet 1980; 2:192-5.
24. Crook DW, Spratt BG. Multiple antibiotic resistance in Streptococcus pneumoniae. Br Med Bull 1998; 54:595-610.
25. Anonymous. Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India. Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN). Lancet 1999; 353:1216-21.
26. Muhe L, Klugman KP. Pneumococcal and Haemophilus influenzae meningitis in a children's hospital in Ethiopia: serotypes and susceptibility patterns. Trop Med Int Health 1999; 4:421-7.
27. Molyneux EM, Walsh AL, Forsyth H, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 2002; 360:211-18.
28. Collignon PJ, Turnidge JD. Antibiotic resistance in Streptococcus pneumoniae. Med J Aust 2000; 173 (suppl):S58-64.
29. Akpede GO, Adeyemi O, Abba AA, Sykes RM. Pattern and antibiotic susceptibility of bacteria in pyogenic meningitis in a children's emergency room population in Maiduguri, Nigeria, 1988-1992. Acta Paediatr 1994; 83:719-23.
30. Hoban D, Doern G, Fluit A, Roussel-Delvallez M, Jones R. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis 2001; 32:S81-93.
31. Emele FE. Etiologic spectrum and pattern of antimicrobial drug susceptibility in bacterial meningitis in Sokoto, Nigeria. Acta Paediatr 2000; 89:942-6.
32. Friedland IR, Shelton S, McCracken GH. Chloramphenicol in penicillin-resistant pneumococcal meningitis. Lancet 1993; 342:240-1.
33. Klugman KP, Madhi SA. Emergence of drug resistance. Impact on bacterial meningitis. Infect Dis Clin North Am 1999; 13:637-46.
34. Curtis N, Duke T, Fuller D, Shann F. Bacterial meningitis in developing countries? The problem worsens. Lancet 2003; 361:1564.
35. Koumare B, Bougoudogo F, Cisse M, Doumbia T, Keita MM. Bacteriological aspects of purulent meningitis in Bamako district. A propos of 1,541 bacterial strains collected from 1979 to 1991. Bull Soc Pathol Exot 1993; 86:136-40.
36. Saez-Nito J, Lujan R, Berron S. Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: a 5 year history (1985-89). Clin Infect Dis 1992; 14:394-402.
37. Lennon D. Antimicrobials in the management of invasive meningococcal disease. J Pediatr Child Health 2001; 37:105-7.
38. Galimand M, Gerbaud G, Guibourdenche M, Riou JY, Courvalin P. High-level chloramphenicol resistance in Neisseria meningitidis. N Engl J Med 1998; 339:868-74.
39. Goldani LZ. Inducement of Neisseria meningitidis resistance to ampicillin and penicillin in a patient with meningococcemia treated with high doses of ampicillin. Clin Infect Dis 1998; 26:772.
40. UNICEF. The state of the world's children, 2001. Geneva: UNICEF, 2001.
41. O'Dempsey TJ, McArdle TF, Morris J, et al. A study of risk factors for pneumococcal disease among children in a rural area of West Africa. Int J Epidemiol 1996; 25:885-93.
42. Man WD, Weber M, Palmer A, et al. Nutritional status of children admitted to hospital with different diseases and its relationship to outcome in The Gambia, West Africa. Trop Med Int Health 1998; 3:678-86.
43. Shann F. Chloramphenicol for meningitis and pneumonia. Lancet 1986; 1:507.
44. Duke T. Fluid management of bacterial meningitis in developing countries. Arch Dis Child 1998; 79:181-5.
45. Macfarlane S, Racelis M, Muli-Musiime F. Public health in developing countries. Lancet 2000; 356:841-6.
46. Salih MA, el Hag AI, Sid Ahmed H, et al. Endemic bacterial meningitis in Sudanese children: aetiology, clinical findings, treatment and short-term outcome. Ann Trop Paediatr 1990; 10:203-10.
47. Schutte CM. Clinical, cerebrospinal fluid and pathological findings and outcomes in HIV-positive and HIV-negative patients with tuberculous meningitis. Infection 2001; 29:213-17.
48. Mwaba P, Mwansa J, Chintu C, et al. Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal chmeningitis in Zambian AIDS patients treated under local conditions. Postgrad Med J 2001; 77:769-73.
49. Madhi SA, Madhi A, Peterson K, Khoosal M, Klugman KP. Impact of human immunodeficiency virus type 1 on the epidemiology and outcome of bacterial meningitis in South African children. Int J Infect Dis 2001; 5:119-25.
50. Leibovitz E, Dragomir C, Sfartz S, et al. Nasopharyngeal carriage of multidrug-resistant Streptococcus pneumoniae in institutionalized HIV-infected and HIV-negative children in northeastern Romania. Int J Infect Dis 1999; 3:211-15.
51. World Health Organization. Management of the Child with a Serious Infection or Severe Malnutrition - Guidelines for Care at the First Referral Level in Developing Countries. Geneva: WHO, 1998; 61-4.
52. Phillips R, Ball C, Sackett D, et al. Levels of evidence and grades of recommendation. Available at: www.cebm.jr2.ox.ac.uk/docs/levels.html, 2001. Accessed December 2001.
53. Jawetz E, Gunnison J, Speck R, Coleman V. Studies on antibiotic synergism and antagonism. Arch Intern Med 1951; 87:349-59.
54. Ware SJ, McLaughlin S. Haemophilus meningitis in Portsmouth. Lancet 1978; 2:197-9.
55. Lindberg J, Rosenhall U, Nylen O, Ringner A. Long-term outcome of Hemophilus influenzae meningitis related to antiobiotic treatment. Pediatrics 1977; 60:1-6.
56. Akpede GO, Dawodu SO, Umoffia ME. Response to antimicrobial therapy in childhood bacterial meningitis in tropical Africa: report of a bi-centre experience in Nigeria, 1993-1998. Ann Trop Paediatr 1999; 19:237-43.
57. Kumar P, Verma IC. Antibiotic therapy for bacterial meningitis in children in developing countries. Bull WHO 1993; 71:183-8.
58. Tetanye E, Yondo D, Bernard-Bonnin AC, et al. Initial treatment of bacterial meningitis in Yaounde, Cameroon: theoretical benefits of the ampicillin-chloramphenicol combination versus chloramphenicol alone. Ann Trop Paediatr 1990; 10:285-91.
59. Shann F, Barker J, Poore P. Chloramphenicol alone versus chloramphenicol plus penicillin for bacterial meningitis in children. Lancet 1985; 2:681-4.
60. Haffejee IE. Cefotaxime versus penicillin-chloramphenicol in purulent meningitis: a controlled single-blind clinical trial. Ann Trop Paediatr 1988; 8:225-9.
61. Odio CM, Faingezicht I, Salas JL, Guevara J, Mohs E, McCracken GH. Cefotaxime vs conventional therapy for the treatment of bacterial meningitis of infants and children. Pediatr Infect Dis 1986; 5:402-7.
62. Jacobs RF, Wells TG, Steele RW, Yamauchi T. A prospective randomized comparison of cefotaxime vs ampicillin and chloramphenicol for bacterial meningitis in children. J Pediatr 1985; 107:129-33.
63. Wells TG, Trang JM, Brown AL, Marmer BC, Jacobs RF. Cefotaxime therapy of bacterial meningitis in children. J Antimicrob Chemother 1984; 14 (suppl B):181-9.
64. Sharma PR, Adhikari RK, Joshi MP, et al. Intravenous chloramphenicol plus penicillin versus intramuscular ceftriaxone for the treatment of pyogenic meningitis in Nepalese children. Trop Doct 1996; 26:84-5.
65. Girgis NI, Abu el Ella AH, Farid Z, Haberberger RL, Galal FS, Woody JN. Intramuscular ceftriaxone versus ampicillin-chloramphenicol in childhood bacterial meningitis. Scand J Infect Dis 1988; 20:613-17.
66. Ngu J, Youmbissi T. A comparative study with ceftriaxone (Rocephin) versus ampicillin and chloramphenicol in children with bacterial meningitis. Chemioterapia 1987; 6 (suppl):417-18.
67. Barson WJ, Miller MA, Brady MT, Powell DA. Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children. Pediatr Infect Dis 1985; 4:362-8.
68. Bryan JP, Rocha H, da Silva HR, Taveres A, Sande MA, Scheld WM. Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis. Antimicrob Agents Chemother 1985; 28:361-8.
69. Aronoff SC, Reed MD, O'Brien CA, Blumer JL. Comparison of the efficacy and safety of ceftriaxone to ampicillin/chloramphenicol in the treatment of childhood meningitis. J Antimicrob Chemother 1984; 13:143-51.
70. Congeni BL. Comparison of ceftriaxone and traditional therapy of bacterial meningitis. Antimicrob Agents Chemother 1984; 25:40-4.
71. del Rio MA, Chrane D, Shelton S, McCracken GH, Nelson JD. Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children. Lancet 1983; 1:1241-4.
72. Steele RW, Bradsher RW. Comparison of ceftriaxone with standard therapy for bacterial meningitis. J Pediatr 1983; 103:138-41.
73. Peltola H, Anttila M, Renkonen OV. Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group [see comments]. Lancet 1989; 1:1281-7.
74. Rodriguez WJ, Puig JR, Khan WN, Feris J, Gold BG, Sturla C. Ceftazidime vs. standard therapy for pediatric meningitis: therapeutic, pharmacologic and epidemiologic observations. Pediatr Infect Dis 1986; 5:408-15.
75. Smith AL, Weber A. Pharmacology of chloramphenicol. Pediatr Clin North Am 1983; 30:209-36.
76. Mehta S, Kalsi HK, Jayaraman S, Mathur VS. Chloramphenicol metabolism in children with protein-calorie malnutrition. Am J Clin Nutr 1975; 28:977-81.
77. Yogev R, Kolling WM, Williams T. Pharmacokinetic comparison of intravenous and oral chloramphenicol in patients with Haemophilus influenzae meningitis. Pediatrics 1981; 67:656-60.
78. Pickering LK, Hoecker JL, Kramer WG, Kohl S, Cleary TG. Clinical pharmacology of two chloramphenicol preparations in children: sodium succinate (iv) and palmitate (oral) esters. J Pediatr 1980; 96:757-61.
79. Tuomanen EI, Powell KR, Marks MI, et al. Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis. J Pediatr 1981; 99:968-74.
80. Schreiner M, Schaible D, Fleisher G. Intramuscular chloramphenicol in children. N Engl J Med 1986; 314:451.
81. Shann F, Mackenzie A. Intramuscular chloramphenicol in children. N Engl J Med 1986; 314:451.
82. Coakley JC, Hudson I, Shann F, Connelly JF. A review of therapeutic monitoring of chloramphenicol in patients with Haemophilus influenzae meningitis. J Pediatr Child Health 1992; 28:249-53.
83. World Health Organization. Antimicrobial and support therapy for bacterial meningitis in children. Report of meeting on 18-20 June 1997, Geneva, Switzerland. Geneva: WHO, 1998; 5-6.
84. Ministry of Health, Papua New Guinea. Paediatric Treatment Protocols, Port Moresby, 2000.
85. Shann F, Linnemann V, Mackenzie A, Barker J, Gratten M, Crinis N. Absorption of chloramphenicol sodium succinate after intramuscular administration in children. N Engl J Med 1985; 313:410-14.
86. Lewis RF, Dorlencourt F, Pinel J. Long-acting oily chloramphenicol for meningococcal meningitis. Lancet 1998; 352:823.
87. Puddicombe JB, Wali SS, Greenwood BM. A field trial of a single intramuscular injection of long-acting chloramphenicol in the treatment of meningococcal meningitis. Trans R Soc Trop Med Hyg 1984; 78:399-403.
88. Mohammed I, Nasidi A, Alkali AS, et al. A severe epidemic of meningococcal meningitis in Nigeria, 1996. Trans R Soc Trop Med Hyg 2000; 94:265-70.
89. Pecoul B, Varaine F, Keita M, et al. Long-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis. Lancet 1991; 338:862-6.
90. O'Neill P. How long to treat bacterial meningitis. Lancet 1993; 341:530.
91. Viladrich PF, Pallares R, Ariza J, Rufi G, Gudiol F. Four days of penicillin therapy for meningococcal meningitis. Arch Intern Med 1986; 146:2380-2.
92. Lin TY, Chrane DF, Nelson JD, McCracken GH Jr. Seven days of ceftriaxone therapy is as effective as ten days' treatment for bacterial meningitis. JAMA 1985; 253:3559-63.
93. Roine I, Ledermann W, Foncea LM, Banfi A, Cohen J, Peltola H. Randomized trial of four vs. seven days of ceftriaxone treatment for bacterial meningitis in children with rapid initial recovery. Pediatr Infect Dis J 2000; 19:219-22.
94. McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 1997; 278:925-31.
95. Geiman BJ, Smith AL. Dexamethasone and bacterial meningitis. A meta-analysis of randomized controlled trials. West J Med 1992; 157:27-31.
96. Girgis NI, Farid Z, Mikhail IA, Farrag I, Sultan Y, Kilpatrick ME. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J 1989; 8:848-51.
97. Ciana G, Parmar N, Antonio C, Pivetta S, Tamburlini G, Cuttini M. Effectiveness of adjunctive treatment with steroids in reducing short-term mortality in a high-risk population of children with bacterial meningitis. J Trop Pediatr 1995; 41:164-8.
98. Qazi SA, Khan MA, Mughal N, et al. Dexamethasone and bacterial meningitis in Pakistan. Arch Dis Child 1996; 75:482-8.
99. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347:1549-56.
100. Duke T, Michael A, Mokela D, Wal T, Reeder J. Chloramphenicol or ceftriaxone, or both, as treatment for meningitis in developing countries? Arch Dis Child 2003; 88:536-9.
101. Campagne G, Chippaux JP, Djibo S, Issa O, Garba A. Epidemiology and control of bacterial meningitis in children less than 1 year in Niamey (Niger). Bull Soc Pathol Exot 1999; 92:118-22.
102. Duke T, Curtis N, Fuller DG. The management of bacterial meningitis in children. Expert Opin Pharmacother 2003; 4:1227-40.